170 related articles for article (PubMed ID: 35181913)
1. Sacral neuromodulation in patients with detrusor underactivity: Is biological sex an indicator?
Onur R; Tayebi S; Salehi-Pourmehr H; Jahantabi E; Perrouin-Verbe MA; Naseri C; Hajebrahimi S; Hashim H
Neurourol Urodyn; 2022 Mar; 41(3):847-859. PubMed ID: 35181913
[TBL] [Abstract][Full Text] [Related]
2. Does sacral neuromodulation lead to relevant reduction in the need for intermittent catheterization? A single-center experience on patients with chronic urinary retention.
Denzinger S; Nowrotek A; Weingart P; Burger M; Wieland WF; Rößler W; Otto W
Neuromodulation; 2012; 15(6):586-91; discussion 591. PubMed ID: 22672285
[TBL] [Abstract][Full Text] [Related]
3. Two-Staged Sacral Neuromodulation for the Treatment of Nonobstructive Urinary Retention: A Multicenter Study Assessing Predictors of Success.
Coolen RL; Groen J; Stillebroer AB; Scheepe JR; Witte LPW; Blok BFM
Neuromodulation; 2023 Dec; 26(8):1823-1830. PubMed ID: 35690510
[TBL] [Abstract][Full Text] [Related]
4. [Sacral neuromodulation in under- and overactive detrusor-quo vadis? : Principles and developments].
Girtner F; Burger M; Mayr R
Urologe A; 2019 Jun; 58(6):634-639. PubMed ID: 31139864
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of pre-operative bladder contractility as a predictor of improved response rate to a staged trial of sacral neuromodulation in patients with detrusor underactivity.
Chan G; Qu LG; Gani J
World J Urol; 2021 Jun; 39(6):2113-2119. PubMed ID: 32725304
[TBL] [Abstract][Full Text] [Related]
6. [Therapeutic effects of sacral neuromodulation on detrusor underactivity].
Wang Q; Zhang WY; Liu XH; Wang MR; Lai JH; Hu H; Xu T; Xu KX
Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Aug; 53(4):671-674. PubMed ID: 34393226
[TBL] [Abstract][Full Text] [Related]
7. [Effectiveness and safety of sacral neuromodulation on neurogenic bladder and bowel dysfunction in patients with spina bifida].
Chen G; Wang Y; Ying X; Pang D; Liao L
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2021 Nov; 35(11):1374-1379. PubMed ID: 34779161
[TBL] [Abstract][Full Text] [Related]
8. [Sacral neuromodulation in urology. The emperor's new clothes or effective high-tech medicine?].
Hoda MR; Fornara P
Urologe A; 2010 Oct; 49(10):1254-9. PubMed ID: 20859609
[TBL] [Abstract][Full Text] [Related]
9. Sacral neuromodulation outcomes in male patients with chronic urinary retention.
Saber-Khalaf M; Abtahi B; Gonzales G; Helal M; Elneil S
Neuromodulation; 2015 Jun; 18(4):329-34; discussion 334. PubMed ID: 25655708
[TBL] [Abstract][Full Text] [Related]
10. Results of Sacral Neuromodulation Therapy for Urinary Voiding Dysfunction: Five-Year Experience of a Retrospective, Multicenter Study in China.
Zhang P; Wang JY; Zhang Y; Liao L; Lv JW; Ling Q; Wei ZQ; Zhong T; Xu ZH; Wen W; Li JY; Luo DY
Neuromodulation; 2019 Aug; 22(6):730-737. PubMed ID: 30609180
[TBL] [Abstract][Full Text] [Related]
11. Sacral neuromodulation in patients with multiple sclerosis.
Minardi D; Muzzonigro G
World J Urol; 2012 Feb; 30(1):123-8. PubMed ID: 21400258
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of sacral neuromodulation for lower urinary tract dysfunction.
Peeters K; Sahai A; De Ridder D; Van Der Aa F
BJU Int; 2014 May; 113(5):789-94. PubMed ID: 24238278
[TBL] [Abstract][Full Text] [Related]
13. Sacral neuromodulation in patients with idiopathic overactive bladder after initial botulinum toxin therapy.
Smits MA; Oerlemans D; Marcelissen TA; Van Kerrebroeck PE; De Wachter SG
J Urol; 2013 Dec; 190(6):2148-52. PubMed ID: 23872028
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of Sacral Neuromodulation by Converting Constant Frequency Stimulation Into Variable Frequency Stimulation in Patients With Detrusor Overactivity and Impaired Contractility: A Single-Center Prospective Study.
Zhu W; Shan S; Zhang G; Zhang Q; Zhang J; Che Y; Wen J; Wang Q
Neuromodulation; 2023 Dec; 26(8):1836-1844. PubMed ID: 35977853
[TBL] [Abstract][Full Text] [Related]
15. New sacral neuromodulation lead for percutaneous implantation using local anesthesia: description and first experience.
Spinelli M; Giardiello G; Gerber M; Arduini A; van den Hombergh U; Malaguti S
J Urol; 2003 Nov; 170(5):1905-7. PubMed ID: 14532804
[TBL] [Abstract][Full Text] [Related]
16. Video-urodynamics efficacy of sacral neuromodulation for neurogenic bladder guided by three-dimensional imaging CT and C-arm fluoroscopy: a single-center prospective study.
Shan S; Zhu W; Zhang G; Zhang Q; Che Y; Wen J; Wang Q
Sci Rep; 2022 Sep; 12(1):16306. PubMed ID: 36175471
[TBL] [Abstract][Full Text] [Related]
17. Intravesical electrostimulation versus sacral neuromodulation for incomplete spinal cord patients suffering from neurogenic non-obstructive urinary retention.
Lombardi G; Musco S; Celso M; Ierardi A; Nelli F; Del Corso F; Del Popolo G
Spinal Cord; 2013 Jul; 51(7):571-8. PubMed ID: 23628893
[TBL] [Abstract][Full Text] [Related]
18. Effects of Appropriate Prolonged Sacral Neuromodulation Testing in Improving Implantation Rate of a Permanent Implantable Pulse Generator in Patients with Refractory Lower Urinary Tract Dysfunctions in Mainland China.
Zhang P; Zhang JZ; Wu LY; Zhang XD
Chin Med J (Engl); 2017 Feb; 130(4):439-444. PubMed ID: 28218218
[TBL] [Abstract][Full Text] [Related]
19. Optimal Lead Positioning in Sacral Neuromodulation: Which Factors Are Related to Treatment Outcome?
Jairam R; Marcelissen T; van Koeveringe G; van Kerrebroeck P
Neuromodulation; 2017 Dec; 20(8):830-835. PubMed ID: 28877395
[TBL] [Abstract][Full Text] [Related]
20. Detailed Investigation of Bladder Diary Parameters During Sacral Neuromodulation in Patients With Overactive Symptoms.
Van de Borne S; Tilborghs S; Vaganée D; Vermandel A; De Wachter S
Neuromodulation; 2023 Dec; 26(8):1831-1835. PubMed ID: 36266179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
